Attached files
file | filename |
---|---|
10-Q - Predictive Oncology Inc. | v199262_10q.htm |
EX-3.1 - Predictive Oncology Inc. | v199262_ex3-1.htm |
EX-3.2 - Predictive Oncology Inc. | v199262_ex3-2.htm |
EX-31.1 - Predictive Oncology Inc. | v199262_ex31-1.htm |
EX-31.2 - Predictive Oncology Inc. | v199262_ex31-2.htm |
CERTIFICATION
PURSUANT
TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO SECTION 906
OF
THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report on Form 10-Q of BioDrain Medical, Inc. (the
“Company”) for the quarter ended September 30, 2010 as filed with the Securities
and Exchange Commission (the “Report”), I, Kevin R. Davidson, Chief Executive
Officer (Principal Executive Officer) and Chief Financial Officer (Principal
Financial Officer) of the Company, hereby certify as of the date hereof, solely
for purposes of § 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1350, that
to the best of my knowledge:
(1)
The Report fully complies with the requirements of
Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934,
and
(2)
The information contained in the Report fairly
presents, in all material respects, the financial condition and results of
operations of the Company at the dates and for the periods
indicated.
Date:
November 12, 2010
|
/s/
Kevin R. Davidson
|
|
Kevin
R. Davidson
|
||
Chief
Executive Officer (Principal Executive Officer) and Chief Financial
Officer (Principal Financial Officer)
|